Boston Scientific said in the letter that it is actively developing a software update for the affected devices designed to ...

Certain Accolade pacemakers can permanently enter safety mode, which limits the devices’ ability to treat patients properly ...

Medtronic PLC (NYSE: MDT) is synonymous with medical devices for chronic conditions like diabetes, pain disorders, and pulmonary diseases. The company is well-known for its extensive lineup of cardiac ...

The "Cardiac Resynchronization Therapy (CRT) - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The cardiac resynchronization therapy ...

More than 20,000 pacemakers are implanted each year in India and the numbers are growing annually. Despite this, there is no ...

As the market for leadless pacemakers grows in India, doctors point out definite advantages of the technology for heart ...

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers ...

The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...

Medtronic Percept neurostimulators send electrical signals through thin wires to specific brain regions affected by ...

The Percept™ neurostimulators are equipped with sensing capabilities that help doctors provide tailored treatments for ...

The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...

Now retired and living in Hawaii, it was Bakken’s pacemaker that was largely responsible for building the company’s reputation. Medtronic partnership Bob Hanvik, Medtronic spokesman, said the company ...